The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
Open accessAbstract
The pathogenesis of type 2 diabetes involves abnormalities in insulin action, insulin secretion, and endogenous glucose output (EGO). However, the sequence with which these abnormalities develop and their relative contributions to the deterioration in glucose tolerance remain unclear in the absence of a detailed longitudinal study. We measured insulin action, insulin secretion, and EGO longitudinally in 17 Pima Indians, in whom glucose tolerance deteriorated from normal (NGT) to impaired (IGT) to diabetic over 5.1 +/- 1.4 years. Transition from NGT to IGT was associated with an increase in body weight, a decline in insulin-stimulated glucose disposal, and a decline in the acute insulin secretory response (AIR) to intravenous glucose, but no change in EGO. Progression from IGT to diabetes was accompanied by a further increase in body weight, further decreases in insulin-stimulated glucose disposal and AIR, and an increase in basal EGO. Thirty-one subjects who retained NGT over a similar period also gained weight, but their AIR increased with decreasing insulin-stimulated glucose disposal. Thus, defects in insulin secretion and insulin action occur early in the pathogenesis of diabetes. Intervention to prevent diabetes should target both abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance and concurrent relative insulin deficiency and glucagon dysregulation underlie T2D pathophysiology.33–35”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“These findings derived from cross-sectional data are supported by a longitudinal study in Pima Indians that has also shown the importance of accounting for the hyperbolic relationship between insulin sensitivity and insulin secretion and demonstrated the presence of impaired beta-cell function in those destined to progress to Type 2 diabetes [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Seventeen (35%) of these subjects progressed from NGT to IGT and then to diabetes during follow up.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Our finding of a hyperbolic relationship between insulin sensitivity and insulin secretion in healthy subjects has been confirmed in large cohorts of Danish [94] and Pima Indian subjects [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“During follow up, insulin secretion declined progressively by 78% while insulin sensitivity decreased by only 14%.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Based on the UKPDS [18] and the longitudinal assessment in Pima Indians [95], the major reason for the decline in glucose tolerance seems to be a progressive loss of beta-cell function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Further progressive deterioration of β-cell function accounts for the evolving natural history of the disease from impaired glucose tolerance to type 2 diabetes10,11.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [10]
In the citing paper
“Our results may help explain the aforementioned association between N3 lack and T2DM, as a loss in first-phase insulin secretion is both an early marker of T2DM and part of its pathogenesis (20).”
From Sleep architecture and glucose and insulin homeostasis in obese adolescents (2011) · cites this paper as [20]
In the citing paper
“IGT and T2DM ensue when beta cell function fails to compensate.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
In the citing paper
“Insulin resistance precedes the development of hyperglycemia and T2DM and results in compensatory hyperinsulinemia.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Body composition from fluid spaces and density: analysis of methods. 1961.
Siri, W. E. (1994) · PubMed · Cited by 2,556
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 5×
“It is well known that there is a hyperbolic relationship between early insulin secretion and insulin action in individuals with NGT, meaning that, cross-sectionally, insulin secretion increases with decreasing insulin action and vice versa (51, 52).”
BackgroundMethodInfluentialTechniques for Measuring Body Composition
National Research Council (1961) · National Academies Press eBooks · doi:10.17226/21603 · Cited by 1,620
Flagged first, then by citations
1 of the 68 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- 1998, Diabetes Care, 21(Suppl. 1), S5
- DeFronzo, 1997, Diabetes Reviews, 5, 177
- Abbott, 1990, Am J Physiol, 258, E347
- Bogardus, 1984, J Clin Invest, 78, 1568
- Schwartz, 1995, J Clin Endocrinol Metab, 80, 1571
- Luzi, 1989, Am J Physiol, 257, E241
Cited by
Sorted by citations
Items 801–900 of 1,002
Ahmed, F., Al‐Habori, M., Al-Zabedi, E., & Saif-Ali, R. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00788-5 · Cited by 26
Preservation of Beta-Cell Function in Type 2 Diabetes
Nyalakonda, K., Sharma, T., & Ismail‐Beigi, F. (2010) · Endocrine Practice · doi:10.4158/ep10112.ra · Cited by 25
Gestational Diabetes Mellitus, Fetal Growth and Vitamin D
Yoon, H. K. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.3.155 · Cited by 25
Fusion pore in exocytosis: More than an exit gate? A β-cell perspective
Hastoy, B., Clark, A., Rorsman, P., & Lang, J. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.10.005 · Cited by 25
Pich�, M., Lemieux, S., Përusse, L., & Weisnagel, S. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1701-y · Cited by 25
Chang, A. M., Smith, M. J., Bloem, C. J., Gałecki, A. T., & Halter, J. B. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00156.2004 · Cited by 25
Rich, S. S., Bowden, D. W., Haffner, S. M., Norris, J. M., Saad, M. F., Mitchell, B. D., Rotter, J. I., Langefeld, C. D., Hedrick, C. C., Wagenknecht, L. E., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.1.290 · Cited by 25
Insulin therapy in type 2 diabetes
Davis, T., & Edelman, S. V. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.005 · Cited by 25
Li, T., Jiao, W., Li, W., & Li, H. (2016) · Endocrine Research · doi:10.3109/07435800.2015.1124437 · Cited by 24
Ding, C., Egli, L., Bosco, N., Sun, L., Goh, H. J., Yeo, K. K., Yap, J. J. L., Actis‐Goretta, L., Leow, M. K., & Magkos, F. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.664939 · Cited by 24
Possible involvement of agmatine in neuropharmacological actions of metformin in diabetic mice
Kotagale, N. R., Rahangdale, S. R., Borkar, A., Singh, K., Ikhar, A., Takale, N., Umekar, M. J., & Taksande, B. G. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174255 · Cited by 24
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_2 · Cited by 24
Recent advancements on novel approaches of insulin delivery
Karmakar, S., Bhowmik, M., Laha, B., & Manna, S. (2023) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2023.100253 · Cited by 24
Alshaikhi, S. A., Alamri, A. M., Alzilai, I. Y. A., Alghanimi, A. A., Alrufaidi, A. M. A., Alrufaidi, A. M., Bader, A. E., Abdelmoniem, A., Alshaikh, A. A., Alshaikhi, O. A., et al. (2024) · Future Science OA · doi:10.2144/fsoa-2023-0208 · Cited by 24
Insulin resistance and carotid atherosclerosis in patients with type 2 diabetes
Park, S. W., Kim, S. K., Cho, Y.-W., Kim, D. J., Song, Y.-D., Choi, Y. J., Huh, B. W., Choi, S. H., Jee, S. H., Cho, M. A., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.006 · Cited by 24
Wang, C., Li, X., Mu, K., Li, L., Wang, S., Zhu, Y., Zhang, M., Ryu, J., Xie, Z., Shi, D., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2971-4 · Cited by 24
Hoenig, M. E. (2014) · Veterinary Sciences · doi:10.3390/vetsci1020121 · Cited by 24
The utility of the C‐peptide in the phenotyping of patients candidates for pancreas transplantation
Esmatjes, E., Fernández, C. G., Rueda, S., Nicolau, J., Chiganer, G., Ricart, M. J., Junca, E., & Fernández‐Cruz, L. (2007) · Clinical Transplantation · doi:10.1111/j.1399-0012.2007.00649.x · Cited by 24
Cardiorespiratory fitness predicts insulin action and secretion in healthy individuals
Larsen, F. J., Anderson, M. P., Ekblom, B. T., & Nyström, T. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.010 · Cited by 24
Florez, H. J., Scranton, R. E., Farwell, W. R., DeFronzo, R. A., & Ezrokhi, M. (2011) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000142 · Cited by 24
Park, C. H., Tanaka, T., & Yokozawa, T. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00543 · Cited by 24
Vahidi, O., Kwok, K. E., Gopaluni, R. B., & Knop, F. K. (2015) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-015-1406-4 · Cited by 24
Haugaard, S. B., Andersen, O., Vølund, A., Hansen, B. R., Iversen, J., Andersen, U. B., Nielsen, J. O., & Madsbad, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02223.x · Cited by 24
Mizutani, F., Ohta, E., Mie, Y., Niwa, O., & Yasukawa, T. (2008) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2008.08.037 · Cited by 24
Age or waist as determinant of insulin action?
Bryhni, B., Jenssen, T. G., Olafsen, K., & Eikrem, J. H. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00100-8 · Cited by 24
James, D., Umekwe, N., Edeoga, C., Nyenwe, E., & Dagogo-Jack, S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154263 · Cited by 23
Barbu, E. M., Popescu, M. R., Popescu, A.-C., & Balanescu, S. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136864 · Cited by 23
In-vivo and in-vitro evaluation of therapeutic potential of β- Carotene in diabetes
Nimbalkar, V., Joshi, U., Shinde, S. D., & Pawar, G. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00912-1 · Cited by 23
Dagogo-Jack, S. E., UMEKWE, N. A., Brewer, A., Owei, I., Mupparaju, V. K., Rosenthal, R. H., & Wan, J. Y. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002748 · Cited by 23
Systems analysis and the prediction and prevention of Type 2 diabetes mellitus
Bergman, R. N., Stefanovski, D., & Kim, S. P. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.05.007 · Cited by 23
Fujimoto, S., Mukai, E., & Inagaki, N. (2011) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2011.07.013 · Cited by 23
Omae, N., Ito, M., Hase, S., Nagasawa, M., Ishiyama, J., Ide, T., & Murakami, K. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.013 · Cited by 23
What are the pharmacotherapy options for treating prediabetes?
Daniele, G., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.944160 · Cited by 23
Abuissa, H. S., & O’Keefe, J. H. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00898.x · Cited by 23
Azilsartan Improves Glycemic Status and Reduces Kidney Damage in Zucker Diabetic Fatty Rats
Khan, A. H., Necka, J., Haines, J. F., & Imig, J. D. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu016 · Cited by 23
Rasouli, N., Kern, P. A., Reece, E. A., & Elbein, S. C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00221.2006 · Cited by 23
Aging Does Not Reduce Heat Shock Protein 70 in the Absence of Chronic Insulin Resistance
Kavanagh, K., Wylie, A. T., Chavanne, T. J., Jorgensen, M. J., Voruganti, V. S., Comuzzie, A. G., Kaplan, J. R., McCall, C. E., & Kritchevsky, S. B. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls008 · Cited by 23
Impact of Major Depressive Disorder on Prediabetes by Impairing Insulin Sensitivity
Shelton, R. C., & Li, L. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000664 · Cited by 23
Yu, F., Wang, C., Wang, L., Jiang, H., Ba, Y., Cui, L., Wang, Y., Yu, S., & Li, W.-J. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12413 · Cited by 23
Grancini, V., Trombetta, M., Lunati, M. E., Boselli, M. L., Gatti, S., Donato, M. F., Palmieri, E., Resi, V., Pugliese, G., Bonadonna, R. C., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.015 · Cited by 23
Carmichael, O. T., Stuchlik, P. M., Pillai, S. R., Biessels, G. J., Dhullipudi, R., Madden‐Rusnak, A., Martin, S., Hsia, D. S., Fonseca, V. A., & Bazzano, L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02750 · Cited by 23
Grice, B. A., Barton, K. J., Covert, J. D., Kreilach, A. M., Tackett, L., Brozinick, J. T., & Elmendorf, J. S. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00396.2018 · Cited by 23
Cui, X., Feng, J. B., Wei, T., Gu, L., Wang, D., Lang, S., Yang, K., Yang, J., Yan, H., Wei, R., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104567 · Cited by 23
Nittala, A., Ghosh, S., Stefanovski, D., Bergman, R. N., & Wang, X. (2006) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-5-44 · Cited by 23
Snitker, S., LE, K. Y., Hager, E. R., Caballero, B. H., & Black, M. M. (2007) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.161.7.677 · Cited by 23
Gerstein, H. C., & Rosenstock, J. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.11.002 · Cited by 23
Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus.
Tataranni, P. (2002) · PubMed · Cited by 23
Dagogo-Jack, S. E. (2025) · Diabetes · doi:10.2337/dbi25-0006 · Cited by 22
Wang, J., Jin, C., Ke, J.-F., Ma, Y.-L., Wang, Y., Lu, J., Li, M., & Li, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.942412 · Cited by 22
Review: Pre-diabetes: clinical relevance and therapeutic approach
Pratley, R. E., & Matfin, G. (2007) · The British Journal of Diabetes · doi:10.1177/14746514070070030401 · Cited by 22
Self-citationPatel, S., Santani, D. D., Patel, V., & Shah, M. B. (2014) · Pharmacognosy Research · doi:10.4103/0974-8490.147217 · Cited by 22
β-Cell Dysfunction in Adolescents and Adults with Newly Diagnosed Type 2 Diabetes Mellitus
Elder, D. A., Herbers, P. M., Weis, T., Standiford, D. A., Woo, J. G., & D’Alessio, D. A. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.002 · Cited by 22
Martin, R. M., Patel, R., Zinovik, A., Kramer, M. S., Oken, E., Vilchuck, K., Bogdanovich, N., Sergeichick, N., Gunnarsson, R., Grufman, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046752 · Cited by 22
Protective Effect of Heme Oxygenase-1 on High Glucose-Induced Pancreatic β-Cell Injury
Lee, E.-M., Lee, Y. E., Lee, E., Ryu, G. R., Ko, S., Moon, S., Song, K., & Ahn, Y. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.469 · Cited by 22
Beta-cell function and mass in type 2 diabetes.
Larsen, M. O. (2009) · PubMed · Cited by 22
Retinoids have therapeutic action in type 2 diabetes
Meerza, D., Iqbal, S., Zaheer, S., & Naseem, I. (2016) · Nutrition · doi:10.1016/j.nut.2016.02.003 · Cited by 22
Zhao, Q., Zhang, A., Zong, W., An, N., Zhang, H., Luan, Y., Sun, H. J., Wang, X., & Cao, H. (2017) · RSC Advances · doi:10.1039/c7ra05722a · Cited by 23
François, M. E., Gilbertson, N. M., Eichner, N. Z. M., Heiston, E. M., Fabris, C., Breton, M. D., Mehaffey, J. H., Hassinger, T. E., Hallowell, P. T., & Malin, S. K. (2018) · Nutrients · doi:10.3390/nu10060717 · Cited by 22
Kuo, C., Lu, Y., Hsu, C., Chang, C. C., Chou, R., Liu, L.-K., Chen, L., Huang, P., Chen, J., & Lin, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-27795-2 · Cited by 22
Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis
Antonucci, A., Marucci, A., Trischitta, V., & Paola, R. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020929 · Cited by 22
Sharma, A., Paliwal, G., Upadhyay, N., & Tiwari, A. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0143-4 · Cited by 23
RetractedIncretin-based therapies in type 2 diabetes: A review of clinical results
Bosi, E., Lucotti, P., Setola, E., Monti, L. D., & Piatti, P. M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.003 · Cited by 22
Colberg, S. R., & Swain, D. P. (2000) · The Physician and Sportsmedicine · doi:10.3810/psm.2000.04.843 · Cited by 22
Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes
Monnier, L., Colette, C., Thuan, J., & Lapinski, H. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01623.x · Cited by 22
Kornum, D. S., Støy, J., Kampmann, U., Voss, T. S., Madsen, L. R., Møller, N., & Ovesen, P. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000237 · Cited by 22
Anchi, P., Khurana, A., Swain, D., Samanthula, G., & Godugu, C. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.02.002 · Cited by 22
Diabetes and the metabolic syndrome—When is it best to intervene to prevent?
Haffner, S. M. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.01.002 · Cited by 22
INS VNTR is a QTL for the insulin response to oral glucose in obese children
Santos, C. D., Fallin, M. D., Stunff, C. L., Fur, S. L., & Bougneres, P. F. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2003 · Cited by 22
Derosa, G., Ragonesi, P. D., Carbone, A., Fogari, E., D’Angelo, A., Cicero, A. F. G., & Maffioli, P. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.005 · Cited by 21
RetractedHepatitis C virus infection and diabetes: A complex bidirectional relationship
Ciardullo, S., Mantovani, A., Ciaccio, A., Carbone, M., Invernizzi, P., & Perseghin, G. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109870 · Cited by 21
Social Support in a Diabetes Online Community: Mixed Methods Content Analysis
Semedo, C. D. M., Bath, P. A., & Zhang, Z. (2022) · JMIR Diabetes · doi:10.2196/41320 · Cited by 21
Wang, C., Luo, D., Zheng, L. P., & Zhao, M. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13187 · Cited by 21
Xuan, S., Szabolcs, M. J., Cinti, F., Perincheri, S., Accili, D., & Efstratiadis, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144790 · Cited by 21
The influence of GH treatment on glucose homeostasis in girls with Turner Syndrome: a 7 years study
Baronio, F., Mazzanti, L., Girtler, Y., Tamburrino, F., Lupi, F., Longhi, S., Fanolla, A., & Radetti, G. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3179 · Cited by 21
Jibril, M. M., Hamid, A. A., Ghazali, H. M., Dek, M. S. P., Ramli, N. S., Jaafar, A. H., Jeeven, K., & Mohammed, A. S. (2019) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · doi:10.12691/jfnr-7-1-10 · Cited by 21
The Mechanism of Phillyrin from the Leaves of Forsythia suspensa for Improving Insulin Resistance
Xu, X., Saadeldeen, F. S. A., Xu, L., Zhao, Y., Wei, J., Wang, H., Liu, Z., & Kang, W. (2019) · BioMed Research International · doi:10.1155/2019/3176483 · Cited by 21
Machine learning workflows identify a microRNA signature of insulin transcription in human tissues
Wong, W. K. M., Joglekar, M. V., Saini, V., Jiang, G., Dong, C. X., Chaitarvornkit, A., Maciag, G. J., Gerace, D., Farr, R. J., Satoor, S. N., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102379 · Cited by 21
Islet cell dysfunction in progression to diabetes mellitus.
Spellman, C. (2007) · PubMed · Cited by 21
American Diabetes Association 60th Scientific Sessions,2000
Bloomgarden, Z. T. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.162 · Cited by 21
Mouse models and type 2 diabetes: translational opportunities
McMurray, F., & Cox, R. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9345-3 · Cited by 21
Lehtovirta, M., Kaprio, J. A., Groop, L., Trombetta, M., & Bonadonna, R. C. (2005) · Diabetologia · doi:10.1007/s00125-005-1815-2 · Cited by 21
Marı́n, C., Pérez‐Martínez, P., Delgado‐Lista, J., Gómez, P., Rodríguez, F., Yubero‐Serrano, E. M., García‐Ríos, A., Camargo, A., Pérez‐Jiménez, F., & López‐Miranda, J. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000235 · Cited by 21
Childhood Obesity and the Metabolic Syndrome
Chia, D. J., & Boston, B. A. (2006) · Advances in Pediatrics · doi:10.1016/j.yapd.2006.04.005 · Cited by 21
Impact of different protein sources in the glycemic and insulinemic responses.
de Oliveira, F. C. E., Volp, A. C. P., & Alfenas, R. D. C. G. (2011) · PubMed · doi:10.1590/s0212-16112011000400002 · Cited by 21
Dual effect of advanced glycation end products in pancreatic islet apoptosis
Costal, F., de Oliveira, É. R. N. C., Raposo, A., Machado‐Lima, A., Peixoto, E. B. M. I., Roma, L. P., Santos, L. R. B., de Faria, J. B. L., Carpinelli, Â. R., Giannella‐Neto, D., et al. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2390 · Cited by 21
Davidson, J. A., Parente, E. B., & Gross, J. L. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000600016 · Cited by 21
American Diabetes Association 60th Scientific Sessions,2000
Bloomgarden, Z. T. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.399 · Cited by 21
Development of Insulin Resistance through Induction of miRNA-135 in C2C12 Cells.
Honardoost, M., Arefian, E., Soleimani, M., Soudi, S., & Sarookhani, M. R. (2016) · PubMed Central · doi:10.22074/cellj.2016.4563 · Cited by 21
Targeting beta-cell preservation in the management of type 2 diabetes
Boughton, C. K., Munro, N. M., & Whyte, M. (2017) · British Journal of Diabetes · doi:10.15277/bjd.2017.148 · Cited by 21
Insulin Promoter Factor 1 variation is associated with type 2 diabetes in African Americans
Karim, M. A., Wang, X., Hale, T. C., & Elbein, S. C. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-37 · Cited by 21
Accili, D., Åhrén, B., Boîtard, C., Cerasi, E., Henquin, J. C., & Seino, S. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01296.x · Cited by 21
Tripathy, D., Lindholm, E., Isomaa, B., Saloranta, C., Tuomi, T., & Groop, L. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00113.2003 · Cited by 20
Triglycerides, Glucose Metabolism, and Type 2 Diabetes
Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209910 · Cited by 20
Christensen, M. B., Serifovski, N., Herz, A. M. H., Schmidt, S., Hommel, E. E., RAIMOND, L. H., Perrild, H., Gotfredsen, A., Gæde, P., & Nørgaard, K. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0276 · Cited by 20
A role and mechanism for redox sensing by SENP1 in β-cell responses to high fat feeding
Lin, H., Suzuki, K., Smith, N. P., Li, X., Nalbach, L., Fuentes, S., Spigelman, A. F., Dai, X.-Q., Bautista, A., Ferdaoussi, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44589-x · Cited by 20
Bunout, D. C., Barrera, G., Maza, T. D. L., Avendaño, M., Gattas, V., Petermann, M., & Hirsch, S. (2004) · PubMed · Cited by 20
Broussard, J. L., Kolka, C. M., Castro, A. V., Bediako, I. A., Paszkiewicz, R. L., Szczepaniak, E. W., Szczepaniak, L. S., Knutson, K. L., Kim, S. P., & Bergman, R. N. (2015) · Diabetologia · doi:10.1007/s00125-015-3721-6 · Cited by 20
Alskär, O., Bagger, J. I., Røge, R. M., Knop, F. K., Karlsson, M. O., Vilsbøll, T., & Kjellsson, M. C. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.602 · Cited by 20
The Role of Renin-Angiotensin Agents in Altering the Natural History of Type 2 Diabetes Mellitus
Lardizabal, J. A., & DEEDWANIA, P. C. (2010) · Current Cardiology Reports · doi:10.1007/s11886-010-0138-1 · Cited by 20
Laspa, E., Christen, A., Efstathiadou, Z. A., Johnston, D. G., & Godsland, I. F. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02225.x · Cited by 20
Metadata
- Authors
- Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weyer, Christian
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 787-794
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408438
- OpenAlex
- W2077149049
- Cited by
- 1,940
- References
- 68
- Citations by year
- 2026: 24 · 2025: 53 · 2024: 53 · 2023: 74 · 2022: 63 · 2021: 80 · 2020: 64 · 2019: 64 · 2018: 61 · 2017: 72 · 2016: 88 · 2015: 81 · 2014: 91 · 2013: 85 · 2012: 83
- FWCI
- 44.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, impaired glucose tolerance, Pima Indians, insulin-stimulated glucose disposal, weight gain, diabetes prevention, pathogenesis
- MeSH terms
- Insulin Secretion, Adult, Anthropometry, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Obesity, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
